A PHASE 1, OPEN-LABEL, PERIOPERATIVE STUDY OF IVOSIDENIB (AG-120) AND VORASIDENIB (AG-881) IN RECURRENT IDH1 MUTANT, LOW-GRADE GLIOMA: UPDATED RESULTS

Mellinghoff, I; Cloughesy, T; Wen, P; Taylor, J; Maher, E; Arrillaga-Romany, I; Peters, K; Choi, C; Ellingson, B; Lin, A; Thakur, S; Nicolay, B; Lu, M; Le, K; Yin, F; Tai, F; Schoenfeld, S; Pandya, SS; Hassan, I; Steelman, L; Clarke, J

NEURO-ONCOLOGY, 2019; 21 (): 28